Juan Hincapie-Castillo, Pharm.D., Ph.D., an assistant professor of pharmaceutical outcomes and policy in the University of Florida College of Pharmacy, has been appointed as member of the Editorial Advisory Board, or EAB, of the Journal of the American Pharmacists Association, or JAPhA, for a three-year term. Juan Hincapie Castillo,…
Hincapie-Castillo will collaborate with faculty and staff in The Center for Public Health Law Research on projects and grants in the area of legal epidemiology.
“Applying group-based trajectory modeling in health outcomes research” Presented by Dr. Wei-Hsuan Jenny Lo-Ciganic, Ph.D. Workshop Description: This workshop presents the application of group-based trajectory modeling (GBTM) that captures and embraces the dynamic nature of individual behaviors and medication utilization outcome changes over time. Distinct patterns that change over time may have important implications…
Scott Martin Vouri, Pharm.D., Ph.D., an assistant professor in the department of pharmaceutical outcomes and policy, was recently selected to the U.S. Deprescribing Research Network, or USDeN, Junior Investigative Intensive Program.
The virtual workshop will address how machine learning and data mining techniques can enhance health economics outcomes research.
The study was published in JAMA Open Network and its findings may be valuable for clinical decision-making regarding treatment regimen selection for individuals with advanced melanoma.
Xcenda fellowship program provides Pharm.D. graduates with a prestigious two-year research and educational experience in an outcomes research and market access consulting environment.
At the meeting, she was presented an “Outstanding Service Award,” for her exceptional leadership in the field of drug safety.
Congratulations to Amir Sarayani, Thui Thai, and Juan Hincapie-Castillo for receiving awards for the best abstracts submitted by students / postdocs during the 35th International Conference on Pharmacoepidemiology in Philadelphia. There are hundreds of student abstracts submitted for presentation at the annual meeting and the top three get…
As the lead institution, UF will receive $1.5 million in annual recurrent funding from the state of Florida to support the research mission of the Consortium for Medical Marijuana Clinical Outcomes Research.
